Start Metformin Immediately
For a diabetic patient with a fasting plasma glucose of 220 mg/dL, metformin should be initiated immediately as first-line therapy, starting at 500 mg once or twice daily with food and titrating gradually to a maximum of 2000 mg daily. 1, 2, 3
Why Metformin First
Metformin is the universally recommended first-line oral medication for type 2 diabetes across all major guidelines 1, 2, 3. The evidence supporting this is robust:
- Efficacy: Reduces A1C by approximately 1-2%, lowers hepatic glucose production, and has beneficial effects on cardiovascular mortality compared to sulfonylureas 1, 2
- Safety profile: Does not cause hypoglycemia when used alone and is weight-neutral 4
- Cost: Remains inexpensive and widely available 1, 5
- Cardiovascular benefit: May reduce risk of cardiovascular events and death, with the UKPDS showing significant reductions in myocardial infarction and diabetes-related deaths in overweight patients 2, 3
Practical Dosing Strategy
Start low and go slow to minimize gastrointestinal side effects:
- Begin with 500 mg once or twice daily with meals
- Titrate gradually over weeks to the maximum effective dose of 2000 mg/day
- Extended-release formulations can be given once daily and may improve tolerability 3
Important Caveats
Monitor vitamin B12 levels periodically, as long-term metformin use is associated with deficiency and worsening neuropathy symptoms 1, 2, 3. This is particularly important in patients with anemia or peripheral neuropathy.
Renal function matters: Metformin is safe with eGFR ≥30 mL/min/1.73 m² per updated FDA labeling 1, 3. Contraindicated only when eGFR <30.
When to Consider Insulin Instead
At a glucose of 220 mg/dL, you're below the threshold where insulin would be mandatory. Consider initiating insulin therapy (with or without additional agents) only when 1, 2:
- Blood glucose ≥300 mg/dL (16.7 mmol/L), OR
- A1C ≥10% (86 mmol/mol), OR
- Catabolic features present (weight loss, ketosis, hypertriglyceridemia)
Since your patient has glucose of 220 mg/dL without mention of these severe features, metformin is the appropriate starting point.
Next Steps After Metformin
If metformin monotherapy doesn't achieve target A1C after 3 months at maximum tolerated dose, add a second agent based on patient-specific factors 1, 3:
- If cardiovascular disease, heart failure, or chronic kidney disease present: Add SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit 3, 6
- If no cardiovascular/renal comorbidities: Choose based on efficacy, hypoglycemia risk, weight impact, and cost—options include DPP-4 inhibitors, sulfonylureas, or GLP-1 receptor agonists 1, 3
Do not delay treatment intensification—reassess every 3-6 months and adjust promptly if targets aren't met 3.